Public annual accounts

Dr. Sam Depypere financials

Name: Dr. Sam Depypere financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for Dr. Sam Depypere, with comparable measures and links to available source documents.

Company overview

Registry number

1001271612

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 27, 2026

Financial evidence

Latest movements for Dr. Sam Depypere

2025 versus 2024

Operating line: €97,064
EBITDA: €96,938
Total assets: €153,347
Equity: €122,025

EBITDA margin +99.9% · Equity ratio +79.6%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202530 Sept 2025	€97,064	€96,938	€153,347	€122,025	-
202430 Sept 2024	€62,215	€62,215	€102,203	€48,558	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report